First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1758-9193

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model ; volume:6 ; number:4 ; day:1 ; month:8 ; year:2014 ; pages:1-12 ; date:8.2014
Alzheimer's research & therapy ; 6, Heft 4 (1.8.2014), 1-12, 8.2014

Creator: Kontsekova, Eva

Contributor: Zilka, Norbert
Kovacech, Branislav
Novák, Petr
Novak, Michal
SpringerLink (Online service)

DOI: 10.1186/alzrt278

URN: urn:nbn:de:1111-2016073131873

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:47 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Kontsekova, Eva
Zilka, Norbert
Kovacech, Branislav
Novák, Petr
Novak, Michal
SpringerLink (Online service)

Other Objects (12)

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Ahnenfigur

Tau-Tau

Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Correction: Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain

Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration

Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease

Tau in Alzheimer’s Disease: Pathological Alterations and an Attractive Therapeutic Target

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

Salidroside reduces tau hyperphosphorylation via up-regulating GSK-3β phosphorylation in a tau transgenic Drosophila model of Alzheimer’s disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Ahnenfigur

Tau-Tau

Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Correction: Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain

Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration

Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease

Tau in Alzheimer’s Disease: Pathological Alterations and an Attractive Therapeutic Target

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

Salidroside reduces tau hyperphosphorylation via up-regulating GSK-3β phosphorylation in a tau transgenic Drosophila model of Alzheimer’s disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Ahnenfigur

Tau-Tau

Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Correction: Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain

Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration

Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease

Tau in Alzheimer’s Disease: Pathological Alterations and an Attractive Therapeutic Target

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

Salidroside reduces tau hyperphosphorylation via up-regulating GSK-3β phosphorylation in a tau transgenic Drosophila model of Alzheimer’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Tau-Tau

Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Correction: Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain

Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration

Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease

Tau in Alzheimer’s Disease: Pathological Alterations and an Attractive Therapeutic Target

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

Salidroside reduces tau hyperphosphorylation via up-regulating GSK-3β phosphorylation in a tau transgenic Drosophila model of Alzheimer’s disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Tau-Tau

Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Correction: Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain

Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration

Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease

Tau in Alzheimer’s Disease: Pathological Alterations and an Attractive Therapeutic Target

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

Salidroside reduces tau hyperphosphorylation via up-regulating GSK-3β phosphorylation in a tau transgenic Drosophila model of Alzheimer’s disease

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Tau-Tau

Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain

Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies

Correction: Tau seed amplification assay reveals relationship between seeding and pathological forms of tau in Alzheimer’s disease brain

Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration

Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease

Tau in Alzheimer’s Disease: Pathological Alterations and an Attractive Therapeutic Target

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

Salidroside reduces tau hyperphosphorylation via up-regulating GSK-3β phosphorylation in a tau transgenic Drosophila model of Alzheimer’s disease

Related objects

Reset password